You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Papillary Carcinoma

Showing 26 - 50 of 8,345
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

Recruiting
  • Metastatic Thyroid Papillary Carcinoma
  • +2 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +14 more
Feb 18, 2022

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

RFA Treatment for Papillary Thyroid Microcarcinoma

Recruiting
  • Papillary Thyroid Microcarcinoma
  • Radiofrequency Ablation
  • New York, New York
    Columbia University
Dec 28, 2021

Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

Not yet recruiting
  • Non-Medullary Thyroid Carcinoma
  • Digoxin tablet
  • (no location specified)
Aug 20, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Radioactive Iodine on the Immune System in Thyroid Cancer

Not yet recruiting
  • Thyroid Carcinoma, Nonmedullary
  • Blood drawing
  • Nijmegen, Netherlands
    Radboud University Medical Center
Aug 13, 2023

Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +11 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Drainage, Thyroid Cancer Trial in Hangzhou (no drainage tube applied)

Recruiting
  • Drainage
  • Thyroid Cancer
  • no drainage tube applied
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital School of Medicine Zhejiang Universit
Jun 19, 2022

Papillary Thyroid Microcarcinoma Trial in Hong Kong (Echopulse)

Suspended
  • Papillary Thyroid Microcarcinoma
  • Echopulse
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 17, 2022

Differentiated Thyroid Gland Carcinoma, Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma Trial in Atlanta

Terminated
  • Differentiated Thyroid Gland Carcinoma
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 25, 2021

Carcinoma, Papillary, Follicular Trial in Seoul (Using Neuromonitoring to find EBSLN)

Terminated
  • Carcinoma, Papillary, Follicular
  • Using Neuromonitoring to find EBSLN
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 13, 2022

Kidney Cancer Trial run by the NCI (INC280)

Completed
  • Kidney Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 18, 2021

Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))

Recruiting
  • Bladder Carcinoma in Situ (CIS)
  • ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
Jan 18, 2023

Papillary Thyroid Microcarcinoma, Thyroid Cancer Trial in Seoul (RFA for PTMC)

Recruiting
  • Papillary Thyroid Microcarcinoma
  • Thyroid Cancer
  • RFA for PTMC
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 22, 2021

Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)

Recruiting
  • Metastatic Papillary Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer AJCC v8
  • Atezolizumab
  • +4 more
  • Sacramento, California
  • +38 more
Jan 17, 2023

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

Recruiting
  • Clear Cell Papillary Renal Neoplasm
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 25, 2021

Endometrial Cancer, Papillary Serous Endometrial Carcinoma, Uterine Serous Carcinoma Trial in United States (Niraparib)

Recruiting
  • Endometrial Cancer
  • +4 more
  • New Brunswick, New Jersey
  • +4 more
Mar 17, 2022

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023